Introduction

Shockwave lithotripsy, commonly known as SWL or ESWL, is one of the most important innovations in the history of urinary stone treatment. Before its clinical introduction, many patients with kidney or ureteric stones required open surgery, prolonged hospitalization, and a significant recovery period. The development of extracorporeal shockwave lithotripsy changed this dramatically by allowing selected urinary stones to be fragmented from outside the body without a surgical incision.

The history of SWL is not the story of one single inventor. It is the result of decades of progress involving physics, engineering, aerospace research, experimental medicine, urology, imaging, and industrial development. The journey required more than the simple idea that shock waves could break stones. It required a way to generate controlled shock waves, transmit them safely through the body, focus them accurately on the stone, and localize the stone during treatment.

From early underwater shock wave research to the legendary Dornier HM3, and from piezoelectric systems such as the Richard Wolf Piezolith to electromagnetic and compact platforms from Siemens, EDAP, Technomed, Direx, and Storz Medical, the evolution of SWL reflects one of the most fascinating examples of technology transfer into clinical medicine.

Early Concepts: Shock Waves, Tissue, and Stone Fragmentation

The foundation of SWL began long before the first patient was treated. During and after the Second World War, researchers became increasingly interested in the effects of underwater shock waves and pressure waves on living tissue. This interest was partly driven by the need to understand blast injuries and tissue damage caused by underwater explosions.

These early studies showed that shock waves could travel through water and soft tissue, but their effects became more significant when they encountered structures with different physical properties. This principle would later become highly relevant to urinary stones, which are hard structures surrounded by soft tissue and fluid.

In the 1940s and 1950s, different approaches were explored for stone fragmentation. Ultrasound and pressure waves were studied as possible methods to break stones. Some experiments showed that stones could be damaged or fragmented by mechanical energy, but the methods were not yet practical for safe, non-invasive treatment.

One of the early concepts came from Yutkin, who developed the URAT-1 device in the 1950s. This system used shock waves generated by electrical discharges between two electrodes located at the tip of an endoscope. It was designed to fragment bladder stones. Although URAT-1 was not modern extracorporeal shockwave lithotripsy, it showed an important concept: urinary stones could be fragmented using shock waves rather than removed surgically.

The Aerospace Origin: Dornier and the Shock Wave Observation

A major step toward modern SWL came from an unexpected field: aerospace engineering.

In the 1960s, engineers at Dornier in Friedrichshafen, Germany, were studying the effects of high-speed micrometeorites and raindrops impacting aircraft and aerospace structures. These impacts generated shock waves that could damage solid materials. During this work, researchers observed that shock waves could pass through soft material but damage harder structures.

This observation raised a powerful medical question:

Could shock waves pass through the soft tissues of the human body and fragment a kidney stone without surgery?

The idea was elegant but technically difficult. For clinical use, several challenges had to be solved. A shock wave had to be generated reliably, focused precisely, transmitted safely through the body, and aimed accurately at a stone that could move with respiration or patient position. This required collaboration between engineers, physicists, physicians, universities, and industry.

1971: Häusler and Kiefer Demonstrate Stone Destruction

A critical experimental milestone came in 1971, when Häusler and Kiefer demonstrated in vitro kidney stone destruction using shock waves. This showed that shock waves could fragment urinary calculi under experimental conditions.

This was a major step from theoretical possibility to practical feasibility. It suggested that shock waves could be harnessed for medical stone treatment. However, the path from breaking a stone in the laboratory to safely treating a human patient remained complex.

At this stage, collaboration between Dornier engineers and medical researchers became increasingly important. The central problem was not merely how to break a stone. The real challenge was how to break a stone inside the human body while minimizing damage to surrounding tissue.

1974–1976: The West German Research Project and Electrohydraulic Shock Wave Generation

In 1974, the West German Ministry of Research and Development sponsored a major project to study underwater shock wave generation for medical use. The project brought together Dornier and medical teams in Munich.

This collaboration produced the early experimental lithotripter models known as TM1, TM2, and TM3.

Around this period, Hoff and Behrendt described and patented an important electrohydraulic shock wave generator concept. This system used a high-voltage spark discharge in water and an ellipsoidal reflector to focus the generated shock wave. The principle became central to the early clinical development of SWL.

The electrohydraulic spark-gap concept was important because it allowed shock waves to be generated in water and focused at a defined point. The ellipsoidal reflector design made it possible to concentrate energy at the stone, while the patient’s body was coupled to the shock wave path through water.

TM1, TM2, and TM3: From Experimental Concept to Clinical Feasibility

The first experimental Dornier lithotripter, TM1, was used to study whether underwater shock waves could be transmitted into living tissue and focused on urinary stones. These early experiments helped establish the basic feasibility of extracorporeal stone fragmentation.

The second prototype, TM2, included improvements in the shock wave source and explored ultrasound imaging for stone localization. However, ultrasound imaging at the time was not reliable enough for precise clinical targeting.

This was one of the most important lessons in the development of SWL: a lithotripter is not only a shock wave generator. Imaging and targeting are equally critical.

The third prototype, TM3, introduced biplanar X-ray localization. This was a major step forward because it allowed more accurate stone positioning in three-dimensional space. Biplanar fluoroscopy helped clinicians align the stone with the shock wave focus and made clinical application more realistic.

1979–1980: Dornier HM1 and the First Clinical SWL Treatment

The first clinical lithotripter prototype was the Dornier Human Model 1, known as HM1. It was installed in 1979 at the Institute of Surgical Research of the Ludwig Maximilian University in Munich.

The HM1 was a large and complex system. It used a water bath for shock wave coupling, biplanar fluoroscopy for stone localization, and a patient positioning system to align the stone with the focal point. Before human treatment, extensive animal experiments were performed to evaluate safety and tissue effects.

One practical problem was patient positioning. In the water bath, the patient could float, making accurate stone targeting difficult. This issue was solved by using special straps to stabilize the patient and allow accurate alignment during treatment.

The landmark moment came on 7 February 1980, when the first clinical SWL treatment was performed by Christian Chaussy, Bernd Forssmann, and Dieter Jocham. This was one of the defining moments in modern urology.

For the first time, a kidney stone was treated from outside the body using focused shock waves.

1980–1983: HM2, HM3, and the Birth of Clinical SWL

After the first clinical success with HM1, Dornier continued development. The HM2 followed, and then came the legendary Dornier HM3.

The Dornier HM3 became the first widely successful commercial extracorporeal shockwave lithotripter. It used an electrohydraulic spark-gap shock wave source, an ellipsoidal reflector, a large water bath, biplanar fluoroscopy, and a patient positioning system.

The HM3 was installed in Munich in the early 1980s and introduced commercially in 1983. For many years, it was regarded as the clinical benchmark of SWL and was often described as the “gold standard.”

Its reputation came from several factors: effective stone fragmentation, strong clinical results in selected patients, reliable water bath coupling, and a broad base of clinical experience. However, it was also large, expensive, and required a dedicated installation. Despite this, the HM3 transformed urology and helped establish SWL as a major treatment option for urinary stones.

1984–1985: International Expansion of the Dornier HM3

The success of the HM3 led to rapid international adoption.

The first HM3 lithotripter in the United States was installed in March 1984 at Methodist Hospital in Indianapolis. The United States Food and Drug Administration granted approval for the Dornier HM3 in December 1984. In Japan, the Ministry of Public Welfare approved the HM3 in 1985.

These approvals accelerated the global spread of extracorporeal shockwave lithotripsy. By the mid-1980s, SWL was no longer an experimental treatment. It had become one of the most important advances in the management of urinary stones.

Mid-1980s: Richard Wolf and the Rise of Piezoelectric Lithotripsy

While Dornier’s HM3 was establishing electrohydraulic SWL, other companies explored alternative methods of shock wave generation.

One of the most important developments came from Richard Wolf GmbH in Knittlingen, Germany. Richard Wolf developed piezoelectric lithotripters, including the Piezolith 2200 and later the Piezolith 2300.

Piezoelectric systems used multiple piezoceramic elements arranged in a focusing geometry. When activated by high-voltage pulses, these elements generated pressure waves that converged at a focal point. This represented a very different technical approach from the electrohydraulic spark-gap systems used in the Dornier HM3.

The Richard Wolf Piezolith 2200 was significant because it introduced a real-time inline ultrasound localization concept. This allowed imaging and shock wave targeting to be more closely integrated. The Piezolith systems helped establish piezoelectric lithotripsy as an important branch in the evolution of SWL technology.

Later, Richard Wolf also developed systems such as the Piezolith 2500, continuing the company’s contribution to piezoelectric extracorporeal shockwave lithotripsy.

Late 1980s: Siemens Lithostar and the Move Toward Compact Integrated Systems

The original Dornier HM3 was clinically successful, but it was also large and expensive. As SWL became more established, the next major challenge was to create systems that were smaller, more affordable, and easier to integrate into routine hospital practice.

Siemens Healthcare contributed to this transition with the Lithostar. The Siemens Lithostar represented a move away from the large dedicated water bath model toward a more compact and integrated lithotripter platform.

The Lithostar combined imaging, positioning, and shock wave treatment in a format that was more practical for many hospitals. It reflected an important industry-wide shift: SWL technology was moving from large specialized installations toward versatile clinical systems.

Late 1980s: EDAP, Technomed, and French Contributions to Compact Lithotripsy

French companies also played an important role in the development of compact lithotripters.

EDAP TMS, based in Vaulx-en-Velin, France, developed systems such as the LT01 and LT02. The EDAP LT02 was a piezoelectric extracorporeal shockwave lithotripter and contributed to the growing field of smaller, more practical SWL platforms.

Another French company, Technomed Medical Systems, developed the Sonolith 2000. Like other compact systems of the period, the Sonolith 2000 reflected the effort to make SWL more accessible, less space-consuming, and easier to integrate into clinical workflow.

Together, systems such as the EDAP LT02 and Technomed Sonolith 2000 helped broaden the availability of SWL beyond major dedicated lithotripsy centers.

Late 1980s: Direx Tripter Compact and the Compact Lithotripter Concept

Another important step toward compact lithotripters came from Direx Systems Corporation in Canton, Massachusetts, USA.

Direx introduced the Tripter Compact, which represented a new design philosophy. Instead of using a large fixed water bath system, it combined a C-arm, treatment table, and shock wave generator in a more versatile and affordable configuration.

The Tripter Compact helped demonstrate that SWL systems could be designed in a more flexible way. This idea influenced later generations of lithotripters from multiple manufacturers.

1989 Onward: Storz Medical and the Modulith Concept

Storz Medical AG, based in Tägerwilen, Switzerland, also became an important name in the evolution of lithotripter technology.

Storz Medical developed electromagnetic shock wave systems and introduced the Modulith concept. Unlike flat-coil electromagnetic systems, the Storz Medical design used a cylindrical electromagnetic source with a parabolic reflector to focus shock waves.

The first patient treatment using this concept was successfully performed in 1989. Since then, Storz Medical lithotripters using cylindrical coil technology have been installed worldwide.

The Modulith concept contributed to the development of modular, clinically adaptable lithotripter platforms. Over time, Storz Medical systems became associated with advanced imaging, positioning concepts, and clinically flexible SWL platforms.

The 1990s and Beyond: Smaller, Multifunctional, and Imaging-Guided Systems

By the 1990s, the direction of lithotripter development had changed significantly. The large water bath systems of the early era were gradually replaced by smaller, more compact, and more multifunctional platforms.

Modern lithotripters increasingly incorporated fluoroscopy, ultrasound, or combined imaging approaches. Patient positioning systems improved. Coupling methods evolved. Shock wave sources became more reproducible. Clinical workflows became more practical.

The major technological branches of SWL became clearly established:

Electrohydraulic lithotripters, historically represented by the Dornier HM3, used a spark discharge in water and an ellipsoidal reflector.

Piezoelectric lithotripters, represented by systems such as the Richard Wolf Piezolith and EDAP LT series, used piezoceramic elements to generate focused pressure waves.

Electromagnetic lithotripters, including systems developed by companies such as Siemens and Storz Medical, used electromagnetic principles to generate reproducible shock waves.

Each technology had its own strengths, limitations, focal characteristics, and clinical workflow implications.

Imaging: The Constant Thread in SWL Evolution

Throughout the history of SWL, imaging has remained central.

Early ultrasound localization was explored during the TM2 stage but was not reliable enough at that time. Biplanar X-ray imaging became essential in the early Dornier systems and helped make clinical SWL possible.

Later, ultrasound targeting improved and became an important radiation-free imaging method, especially for selected renal stones. Fluoroscopy remained important for radiopaque stones and ureteric stones.

The evolution of SWL is therefore not only the evolution of shock wave sources. It is also the evolution of stone localization, patient positioning, and real-time treatment control.

Accurate targeting remains one of the most important determinants of SWL success today.

Shock Waves Beyond Urology

Although SWL was developed for urinary stone disease, shock wave technology later expanded into other medical fields.

Extracorporeal shock wave therapy has been used in orthopedics and sports medicine for conditions such as plantar fasciitis, tennis elbow, tendinopathy, delayed fracture healing, and nonunion of fractures.

Shock waves have also been explored in cardiology, dermatology, neurology, wound healing, and other biomedical fields. This wider development shows how a technology born from physics and engineering for stone fragmentation eventually influenced many areas of medicine.

Why This History Still Matters

The history of shockwave lithotripsy remains important because it teaches several lessons that are still relevant today.

First, SWL is not only a device-based treatment. Its success depends on the relationship between technology, imaging, patient selection, stone characteristics, coupling, energy delivery, and operator skill.

Second, SWL was never intended to be a universal solution for every stone. From the beginning, success depended on correct case selection and accurate targeting.

Third, the development of SWL shows that innovation continues after invention. The first clinical treatment in 1980 was only the beginning. The decades that followed brought new shock wave sources, better imaging, compact devices, improved positioning, and more practical clinical workflows.

Finally, the history of SWL shows that non-invasive treatment remains powerful when used correctly. In modern stone care, SWL continues to have an important role, especially when supported by training, careful patient selection, imaging precision, and optimized treatment protocols.

For Lithotripsy Academy, this history is more than a historical chapter. It connects directly with the Academy’s mission: to improve SWL outcomes through structured education, clinical understanding, and technical excellence.

Conclusion

Shockwave lithotripsy changed the management of urinary stones by offering a non-invasive treatment option for selected patients. Its development was not sudden. It emerged from decades of work in shock wave physics, aerospace research, experimental medicine, imaging, and clinical urology.

From Dornier’s aerospace research to the first clinical treatment in Munich, from the HM1 and HM3 to the Richard Wolf Piezolith, Siemens Lithostar, EDAP LT02, Technomed Sonolith, Direx Tripter Compact, and Storz Medical Modulith, the history of SWL is a story of continuous technological evolution.

It is also a story of collaboration. Engineers, physicists, urologists, surgeons, radiologists, universities, industry, and patients all contributed to turning a bold idea into clinical reality.

Today, the future of SWL depends not only on better machines, but also on better education, better training, better patient selection, and better treatment protocols. This is where Lithotripsy Academy can play an important role: preserving the history of shockwave lithotripsy while helping shape its future.